Historical Valuation
Dynavax Technologies Corp (DVAX) is now in the Undervalued zone, suggesting that its current forward PS ratio of 4.70 is considered Undervalued compared with the five-year average of -3.51. The fair price of Dynavax Technologies Corp (DVAX) is between 87.42 to 96.27 according to relative valuation methord. Compared to the current price of 15.41 USD , Dynavax Technologies Corp is Undervalued By 82.37%.
Relative Value
Fair Zone
87.42-96.27
Current Price：15.41
82.37%
Undervalued
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Dynavax Technologies Corp (DVAX) has a current Price-to-Book (P/B) ratio of 3.38. Compared to its 3-year average P/B ratio of 2.57 , the current P/B ratio is approximately 31.56% higher. Relative to its 5-year average P/B ratio of 6.13, the current P/B ratio is about -44.87% higher. Dynavax Technologies Corp (DVAX) has a Forward Free Cash Flow (FCF) yield of approximately 4.46%. Compared to its 3-year average FCF yield of 5.01%, the current FCF yield is approximately -10.98% lower. Relative to its 5-year average FCF yield of 6.20% , the current FCF yield is about -28.11% lower.
P/B
Median3y
2.57
Median5y
6.13
FCF Yield
Median3y
5.01
Median5y
6.20
Competitors Valuation Multiple
AI Analysis for DVAX
The average P/S ratio for DVAX competitors is 106.83, providing a benchmark for relative valuation. Dynavax Technologies Corp Corp (DVAX.O) exhibits a P/S ratio of 4.70, which is -95.6% above the industry average. Given its robust revenue growth of 17.67%, this premium appears unsustainable.
Performance Decomposition
AI Analysis for DVAX
1Y
3Y
5Y
Market capitalization of DVAX increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of DVAX in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is DVAX currently overvalued or undervalued?
Dynavax Technologies Corp (DVAX) is now in the Undervalued zone, suggesting that its current forward PS ratio of 4.70 is considered Undervalued compared with the five-year average of -3.51. The fair price of Dynavax Technologies Corp (DVAX) is between 87.42 to 96.27 according to relative valuation methord. Compared to the current price of 15.41 USD , Dynavax Technologies Corp is Undervalued By 82.37% .
What is Dynavax Technologies Corp (DVAX) fair value?
DVAX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Dynavax Technologies Corp (DVAX) is between 87.42 to 96.27 according to relative valuation methord.
How does DVAX's valuation metrics compare to the industry average?
The average P/S ratio for DVAX's competitors is 106.83, providing a benchmark for relative valuation. Dynavax Technologies Corp Corp (DVAX) exhibits a P/S ratio of 4.70, which is -95.60% above the industry average. Given its robust revenue growth of 17.67%, this premium appears unsustainable.
What is the current P/B ratio for Dynavax Technologies Corp (DVAX) as of Jan 10 2026?
As of Jan 10 2026, Dynavax Technologies Corp (DVAX) has a P/B ratio of 3.38. This indicates that the market values DVAX at 3.38 times its book value.
What is the current FCF Yield for Dynavax Technologies Corp (DVAX) as of Jan 10 2026?
As of Jan 10 2026, Dynavax Technologies Corp (DVAX) has a FCF Yield of 4.46%. This means that for every dollar of Dynavax Technologies Corp’s market capitalization, the company generates 4.46 cents in free cash flow.
What is the current Forward P/E ratio for Dynavax Technologies Corp (DVAX) as of Jan 10 2026?
As of Jan 10 2026, Dynavax Technologies Corp (DVAX) has a Forward P/E ratio of 30.35. This means the market is willing to pay $30.35 for every dollar of Dynavax Technologies Corp’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Dynavax Technologies Corp (DVAX) as of Jan 10 2026?
As of Jan 10 2026, Dynavax Technologies Corp (DVAX) has a Forward P/S ratio of 4.70. This means the market is valuing DVAX at $4.70 for every dollar of expected revenue over the next 12 months.